关注
Yoon-La Choi
Yoon-La Choi
Sungkyunkwan University School of Medicine
在 skku.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
26952015
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery
J Kao, K Salari, M Bocanegra, YL Choi, L Girard, J Gandhi, KA Kwei, ...
PloS one 4 (7), e6146, 2009
9332009
The somatic genomic landscape of chromophobe renal cell carcinoma
CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ...
Cancer cell 26 (3), 319-330, 2014
8142014
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
N Kim, HK Kim, K Lee, Y Hong, JH Cho, JW Choi, JI Lee, YL Suh, BM Ku, ...
Nature communications 11 (1), 2285, 2020
7002020
Early osteolysis following second-generation metal-on-metal hip replacement
YS Park, YW Moon, SJ Lim, JM Yang, G Ahn, YL Choi
JBJS 87 (7), 1515-1521, 2005
4172005
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement
SM Lim, HR Kim, JS Lee, KH Lee, YG Lee, YJ Min, EK Cho, SS Lee, ...
Journal of clinical oncology 35 (23), 2613-2618, 2017
3542017
Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial
J Cho, HS Kim, BM Ku, YL Choi, R Cristescu, J Han, JM Sun, SH Lee, ...
J clin oncol 37 (24), 2162-70, 2019
2662019
Multinational randomized phase III trial with or without consolidation chemotherapy using docetaxel and cisplatin after concurrent chemoradiation in inoperable stage III non …
JS Ahn, YC Ahn, JH Kim, CG Lee, EK Cho, KC Lee, M Chen, DW Kim, ...
J Clin Oncol 33 (24), 2660-6, 2015
2572015
Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ
KM Joo, J Kim, J Jin, M Kim, HJ Seol, J Muradov, H Yang, YL Choi, ...
Cell reports 3 (1), 260-273, 2013
2492013
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer
KA Kwei, YH Kim, L Girard, J Kao, M Pacyna-Gengelbach, K Salari, J Lee, ...
Oncogene 27 (25), 3635-3640, 2008
2412008
Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management
HY Lee, YL Choi, KS Lee, J Han, JI Zo, YM Shim, JW Moon
American Journal of Roentgenology 202 (3), W224-W233, 2014
2282014
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
SH Lee, JK Lee, MJ Ahn, DW Kim, JM Sun, B Keam, TM Kim, DS Heo, ...
Annals of Oncology 28 (2), 292-297, 2017
2172017
Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients
Y Kim, PS Hammerman, J Kim, J Yoon, Y Lee, JM Sun, MD Wilkerson, ...
Journal of clinical oncology 32 (2), 121, 2014
2172014
Liver X receptor mediates hepatitis B virus X protein–induced lipogenesis in hepatitis B virus–associated hepatocellular carcinoma
TY Na, YK Shin, KJ Roh, SA Kang, I Hong, SJ Oh, JK Seong, CK Park, ...
Hepatology 49 (4), 1122-1131, 2009
1902009
High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients
S Park, YL Choi, CO Sung, J An, J Seo, MJ Ahn, JS Ahn, K Park, YK Shin, ...
F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de …, 2012
1832012
BRAF V600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAF V600E-prevalent population
SW Kim, JI Lee, JW Kim, CS Ki, YL Oh, YL Choi, JH Shin, HK Kim, ...
The Journal of Clinical Endocrinology & Metabolism 95 (8), 3693-3700, 2010
1832010
Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy
ST Kim, DH Lim, KT Jang, T Lim, J Lee, YL Choi, HL Jang, JH Yi, KK Baek, ...
Molecular cancer therapeutics 10 (10), 1993-1999, 2011
1792011
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
HT Shin, YL Choi, JW Yun, NKD Kim, SY Kim, HJ Jeon, JY Nam, C Lee, ...
Nature communications 8 (1), 1377, 2017
1722017
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer
YL Choi, M Bocanegra, MJ Kwon, YK Shin, SJ Nam, JH Yang, J Kao, ...
Cancer research 70 (6), 2296-2306, 2010
1712010
Clinical relevance of TNM staging system according to breast cancer subtypes
YH Park, SJ Lee, EY Cho, YL Choi, JE Lee, SJ Nam, JH Yang, JH Shin, ...
Annals of oncology 22 (7), 1554-1560, 2011
1682011
系统目前无法执行此操作,请稍后再试。
文章 1–20